Chipotle Mexican Grill confirmed on Wednesday that the annual financial guidance it released last week does not factor in any potential expenses tied to an ongoing salmonella investigation in Minnesota, a development investors learned as the company's shares showed early signs of recovery after a sharp one-day drop.
Shares of Chipotle, listed under the ticker CMG, rose roughly 3% in early trading on Wednesday, trying to offset a nearly 10% fall registered on Tuesday.
The Minnesota Department of Health said on Tuesday it had identified 110 salmonella cases in the state. Of the 84 people interviewed by health officials, 75 reported having eaten at Chipotle between June 14 and July 14.
In a regulatory filing submitted Wednesday, Chipotle said: "Due to the uncertain nature of any possible outcomes or impacts from the salmonella investigations, our guidance did not include a financial impact from these matters." That statement makes clear the company did not build any potential remediation, legal, or operational costs related to the Minnesota probe into its annual targets.
On Tuesday the company began tracing its ingredients through its supply chain after learning of the potential outbreak. Chipotle identified jalapeños from a single lot as a possible source linked to the Minnesota illnesses, though health authorities have not confirmed a definitive cause. In response the restaurant chain removed the jalapeños from affected locations and replaced them with product from different growers.
Chipotle had signaled on July 29 that the current quarter would likely be its toughest of the year when executives raised the company's annual sales forecast. At that time the company cited consumer caution about dining out related to a separate multistate cyclosporiasis outbreak.
Last week the company posted quarterly results that beat estimates. Following that report, Chipotle updated its outlook and now expects fiscal 2026 comparable restaurant sales to grow in the low single-digit range, an upward revision from its prior forecast of about flat growth.
Context and implications
The filing clarifies that, despite the operational steps Chipotle has taken in response to the Minnesota investigation, any associated costs remain excluded from the company’s published guidance because outcomes remain uncertain. The company's actions to trace ingredients and substitute supplies are factual steps it has taken while health officials continue their inquiries.